CAV1 and metabolic syndrome: Recently, the same intronic polymorphism was related to metabolic syndrome, type 2 diabetes and low HDL cholesterol in a human cohort with European ancestry, and these findings were replicated in an admixed Hispanic group, which represents the first evidence involving CAV1 with lipid alterations in humans .19